No Data
No Data
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
BofA Securities Maintains Illumina(ILMN.US) With Sell Rating, Announces Target Price $90
Express News | Illumina Inc : BofA Global Research Cuts Price Objective to $90 From $110
Icahn Enterprises Increases CVR Partners, Reduces Southwest Gas, Others
Fund Update: ICAHN CARL C Just Disclosed New Holdings
Express News | Carl Icahn Cuts Shared Share Stake in Illumina Inc. by 90.7% to 40,000 Shares - SEC Filing